Understand the endpoint being estimated
TCID50 is the quantity of infectious material expected to produce a positive infection endpoint in 50% of inoculated culture units under defined conditions. The estimate depends on cell system, inoculum volume, incubation, scoring rule, dilution design, and calculation method.
Record each well outcome, dilution, replicate, controls, plate position, scoring time, and any ambiguous or excluded result. A summarized positive count alone loses information needed for review.
Name the calculation method and its convention
Reed–Muench and Spearman–Kärber-style approaches use endpoint-dilution information differently. Calculators can vary in cumulative proportions, log base, interpolation direction, and handling at the limits of the tested range.
A trustworthy calculator must publish the equation and test it against independently verified examples, including increasing and decreasing sequences, no 50% crossing, incomplete dilution series, and ties.
Track dilution direction, volume, and final units
Confirm whether labels represent dilution or reciprocal dilution and whether the series proceeds from concentrated to dilute. Apply starting dilution and inoculum-volume corrections deliberately.
Report units such as TCID50/mL with the calculation basis. Do not confuse TCID50 with plaque-forming units; conversion factors are empirical and system-dependent.
Review controls and the transition pattern
Controls should behave as expected, and positive proportions should generally transition across the dilution series. Non-monotonic patterns can reflect sampling variation, scoring ambiguity, contamination, plate effects, or an inadequate design.
An algorithm can return a value despite a weak or absent crossing. Define when results are non-estimable, censored, repeated, or reported with limitations.
What a trustworthy TCID50 implementation must make explicit
A trustworthy workflow maps every raw endpoint to its dilution and plate position, names and versions the calculation, publishes the convention, checks controls and transition behavior, and defines handling for non-estimable or censored results.
Verify the implementation against independently calculated examples that cover normal sequences, reversed dilution order, no 50% crossing, incomplete series, ties, and volume corrections. The report should show enough intermediate values to reproduce the endpoint rather than presenting only the final titer.
Frequently asked questions
Is TCID50 the same as EC50?
No. TCID50 commonly estimates a quantal infection endpoint across culture units, while EC50 commonly summarizes a graded dose-response effect.
Can TCID50 be converted to PFU?
No universal exact conversion exists. Any factor is assay- and system-dependent and should be empirically justified.
What if the series never crosses 50% positive?
The endpoint may be outside the tested range or non-estimable under the method. Report the defined censoring or repeat action rather than extrapolating silently.